Isabelle Durand-Zaleski

Showing 1-3 of 3 articles

The people left behind: refining priorities for health care during and after the pandemic

Holmes D, Stefanini G, Ntsekhe M, Wijns W, Mossialos E, Durand-Zaleski I

July 17, 2020 | 10.4244/EIJY20M06-01

Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial

Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iñiguez A, Nazzaro M, Oldroyd K, Talwar S, Richardt G, Windhovel U, Urban P, Morice M

February 20, 2018 | 10.4244/EIJ-D-17-00286

Coronary interventions

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study

Varenne O, Cuisset T, Chaib A, Morice M, Sabaté M, Koh T-H, Durand-Zaleski I, Hanon O, Bogaerts K, Sinnaeve P

January 20, 2017 | 10.4244/EIJY15M12_02

1

Latest news

A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…

Intracoronary OCT: State of the Art and Future Directions

Ziad A. Ali et al.

PCR Companion attending EuroPCR? Activate your free subscription!

Access the full Trials Book 2021

(Thanks to the support of Biotronik)

The Complex Relationship Between Geometrical and Functional Results of PCI

Nieves Gonzalo et al.

Fruitful New Data on Left Main PCI: the LEMON Study

Maria D. Radu Juul Jensen et al.

This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...

Valvular disease